YUHSpace: Dept. of Internal Medicine (내과학교실)

YUHSpace

BROWSE

YUHSpace1. College of Medicine (의과대학)Dept. of Internal Medicine (내과학교실)

Dept. of Internal Medicine (내과학교실)

Researcher List

Keyword Cloud

Journal Categories

Highly Cited Articles

Trastuzumab in combination with chemotherapy versus chemotherapy alone f...

Yung-Jue Bang ; Eric Van Cutsem ; Andrea Feyereislova ; Hyun C Chung ; Lin Sh... LANCET, Vol.376(9742) : 687-697, 2010

Osimertinib in Untreated EGFR-Mutated Advanced Non–Small-Cell Lung Cancer

Jean-Charles Soria ; Yuichiro Ohe ; Johan Vansteenkiste ; Thanyanan Reungwetw... NEW ENGLAND JOURNAL OF MEDICINE, Vol.378(2) : 113-125, 2018

Durvalumab after Chemoradiotherapy in Stage III Non-Small-Cell Lung Cancer

S.J. Antonia ; A. Villegas ; D. Daniel ; D. Vicente ; S. Murakami ; R. Hui ; ... NEW ENGLAND JOURNAL OF MEDICINE, Vol.377(20) : 1919-1929, 2017

This table browses all dspace content
Issue Date	Title	Journal Title
2023	Differences of clinical characteristics and outcome in proven invasive Trichosporon infections caused by asahii and non-asahii species	MYCOSES
2023	Primary myelofibrosis-related glomerulopathy with renal extramedullary hematopoiesis	JOURNAL OF NEPHROLOGY
2023	Plain language summary of the TOPAZ-1 study: durvalumab and chemotherapy for advanced biliary tract cancer	FUTURE ONCOLOGY
2023	The 2021 KDIGO blood pressure target and the progression of chronic kidney disease: Findings from KNOW-CKD	JOURNAL OF INTERNAL MEDICINE
2023	Oral Porphyromonas gingivalis infection affects intestinal microbiota and promotes atherosclerosis	JOURNAL OF CLINICAL PERIODONTOLOGY
2023	Patient-Reported Health-Related Quality of Life in KEYNOTE-604: Pembrolizumab or Placebo Added to Etoposide and Platinum as First-Line Therapy for Extensive-Stage SCLC	JTO Clinical and Research Reports
2023	A randomized trial of genotype-guided perindopril use	JOURNAL OF HYPERTENSION
2023	Pembrolizumab Plus Chemotherapy Followed by Pembrolizumab in Patients With Early Triple-Negative Breast Cancer: A Secondary Analysis of a Randomized Clinical Trial	JAMA NETWORK OPEN
2023	Persistent and Recurrent Device-Related Thrombus After Left Atrial Appendage Closure: Incidence, Predictors, and Outcomes	JACC-CARDIOVASCULAR INTERVENTIONS
2023	Surfactant-like photosensitizer for endoscopic duodenal ablation: Modulating meal-stimulated incretin hormones in obese and type 2 diabetes	BIOMATERIALS
2023	Real-world first-line afatinib for advanced EGFR mutation-positive non-small cell lung cancer in Korea: updated survival data	TRANSLATIONAL LUNG CANCER RESEARCH
2023	Amivantamab plus Chemotherapy in NSCLC with EGFR Exon 20 Insertions	NEW ENGLAND JOURNAL OF MEDICINE
2023	Anti-TIGIT Antibody Tiragolumab Alone or With Atezolizumab in Patients With Advanced Solid Tumors: A Phase 1a/1b Nonrandomized Controlled Trial	JAMA ONCOLOGY
2023	Preparation and characterization of lysozyme loaded liposomal dry powder inhalation using non-ionic surfactants	INTERNATIONAL JOURNAL OF PHARMACEUTICS
2023	Cardiorenal Outcomes with Finerenone in Asian Patients with Chronic Kidney Disease and Type 2 Diabetes: A FIDELIO-DKD post hoc Analysis	AMERICAN JOURNAL OF NEPHROLOGY
2023	High Platelet Reactivity Combined with CYP2C19 Genotype in Predicting Outcomes in East Asian Patients Undergoing Percutaneous Coronary Intervention	CLINICAL PHARMACOLOGY & THERAPEUTICS
2023	Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for HER2-negative advanced gastric cancer (KEYNOTE-859): a multicentre, randomised, double-blind, phase 3 trial	LANCET ONCOLOGY
2023	Targeting PEG10 as a novel therapeutic approach to overcome CDK4/6 inhibitor resistance in breast cancer	JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
2023	Efficacy and Safety of Enavogliflozin versus Dapagliflozin as Add-on to Metformin in Patients with Type 2 Diabetes Mellitus: A 24-Week, Double-Blind, Randomized Trial	DIABETES & METABOLISM JOURNAL
2023	Discovery of New Anti-Cancer Agents against Patient-Derived Sorafenib-Resistant Papillary Thyroid Cancer	INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES